Last 54,400 KRW
Change Today +1,200 / 2.26%
Volume 241.4K
024720 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:23 AM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

korea kolmar holdings co ltd (024720) Snapshot

Open
53,200
Previous Close
53,200
Day High
56,900
Day Low
53,000
52 Week High
10/24/14 - 56,900
52 Week Low
11/8/13 - 9,910
Market Cap
891.7B
Average Volume 10 Days
381.6K
EPS TTM
385.00
Shares Outstanding
16.4M
EX-Date
12/27/13
P/E TM
141.3x
Dividend
65.00
Dividend Yield
0.12%
Current Stock Chart for KOREA KOLMAR HOLDINGS CO LTD (024720)

Related News

No related news articles were found.

korea kolmar holdings co ltd (024720) Related Businessweek News

No Related Businessweek News Found

korea kolmar holdings co ltd (024720) Details

Korea Kolmar Holdings Co., Ltd. is engaged in cosmetics and pharmaceutical businesses in South Korea. The company offers various cosmetics, such as skin care, makeup, body care, and hair care products, as well as perfumes, functional cosmetics, and quasi-drugs. It also provides pharmaceutical products and health functional foods. The company was founded in 1990 and is headquartered in Yeongi County, South Korea.

Founded in 1990

korea kolmar holdings co ltd (024720) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

korea kolmar holdings co ltd (024720) Key Developments

Korea Kolmar Holdings Co. Ltd., Annual General Meeting, Mar 28, 2014

Korea Kolmar Holdings Co. Ltd., Annual General Meeting, Mar 28, 2014., at 11:00 Korea Standard Time. Location: municipal road 12-11. Agenda: To consider and approve the consolidated financial statements; to consider incorporation of some changes; to consider the election of directors; to consider the approval of director remuneration; and to consider other references useful for making investment decisions.

Korea Kolmar Holdings Co., Ltd., Annual General Meeting, Jun 26, 2013

Korea Kolmar Holdings Co., Ltd., Annual General Meeting, Jun 26, 2013., at 11:00 Korea Standard Time. Agenda: To consider income statement, of retained earnings; to consider incorporation of some changes; to consider appointment of audit; to consider approval of the remuneration of directors; and to consider approval of auditors limit.

Montreal's Pharmascience Inc. and Korea Kolmar Holdings Enter into an Agreement to Create Pharmascience Korea

Montreal's Pharmascience Inc. and Korea Kolmar Holdings Co., Ltd. announced they have entered into an agreement to create a new company, Pharmascience Korea, which expects to launch Canadian-made bio-equivalent medicines in the country by 2014. The two companies will contribute equal capital amounts into Pharmascience Korea, which will seek approval of the Korea Food and Drug Administration to market a variety of Pharmascience bio-equivalent medicines in Korea by mid-2014. The initial product portfolio will focus on central nervous system medications to treat a variety of psychiatric disorders. The products will be manufactured by Pharmascience at its facility in Montreal which recently underwent a significant expansion and upgrade involving an investment of $40 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
024720:KS 54,400.00 KRW +1,200

024720 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 024720.
View Industry Companies
 

Industry Analysis

024720

Industry Average

Valuation 024720 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 4.4x
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KOREA KOLMAR HOLDINGS CO LTD, please visit www.kolmar.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.